Evaluation of the catalytic activity and cytotoxicity of palladium nanocubes: the role of oxygen.

ACS Appl Mater Interfaces

†Department of Chemistry and Biochemistry, New Mexico State University, Las Cruces, New Mexico 88003, United States.

Published: May 2015

Recently, it has been reported that palladium nanocubes (PdNC) are capable of generating singlet oxygen without photoexcitation simply via chemisorption of molecular oxygen on its surface. Such a trait would make PdNC a highly versatile catalyst suitable in organic synthesis and a Reactive Oxygen Species (ROS) inducing cancer treatment reagent. Here we thoroughly investigated the catalytic activity of PdNC with respect to their ability to produce singlet oxygen and to oxidize 3,3',5,5'-tetramethylbenzidine (TMB), and analyzed the cytotoxic properties of PdNC on HeLa cells. Our findings showed no evidence of singlet oxygen production by PdNC. The nanocubes' activity is not necessarily linked to activation of oxygen. The oxidation of substrate on PdNC can be a first step, followed by PdNC regeneration with oxygen or other oxidant. The catalytic activity of PdNC toward the oxidation of TMB is very high and shows direct two-electron oxidation when the surface of the PdNC is clean and the ratio of TMB/PdNC is not very high. Sequential one electron oxidation is observed when the pristine quality of PdNC surface is compromised by serum or uncontrolled impurities and/or the ratio of TMB/PdNC is high. Clean PdNC in serum-free media efficiently induce apoptosis of HeLa cells. It is the primary route of cell death and is associated with hyperpolarization of mitochondria, contrary to a common mitochondrial depolarization initiated by ROS. Again, the effects are very sensitive to how well the pristine surface of PdNC is preserved, suggesting that PdNC can be used as an apoptosis inducing agent, but only with appropriate drug delivery system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663053PMC
http://dx.doi.org/10.1021/am509124xDOI Listing

Publication Analysis

Top Keywords

pdnc
13
catalytic activity
12
singlet oxygen
12
palladium nanocubes
8
oxygen
8
activity pdnc
8
hela cells
8
surface pdnc
8
ratio tmb/pdnc
8
tmb/pdnc high
8

Similar Publications

A study on the exploration of mild cognitive impairment in Parkinson's disease based on decision-making cognitive computing.

Front Neurosci

January 2025

Department of Neurology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.

Mild cognitive impairment in Parkinson's disease (PD-MCI) as an independent risk factor for dementia in Parkinson's disease has prognostic value in predicting dementia in PD patients. It was found that the calculation of cognitive function decision-making could better evaluate the cognitive function of PD-MCI. Therefore, this study explored deficits in decision-making cognitive function in PD-MCI population, and mined novel digital biomarkers for recognizing early cognitive decline in PD-MCI through an independently designed maze decision-making digital assessment paradigm.

View Article and Find Full Text PDF

The hydrogenation of bicarbonate, a byproduct of CO captured in alkaline solutions, into formic acid (FA) using glycerol (GLY) as a hydrogen source offers a promising carbon-negative strategy for reducing CO emissions. While Pd-based catalysts are effective in this reaction, they often require high temperatures, leading to low FA yield due to strong hydrogen adsorption on Pd surfaces. In this work, metal-organic framework derived N-doped carbon encapsulated CoNi alloy nanoparticles (CoNi@NC) were prepared, acid-leached, and employed as a support to modulate the electronic structure of Pd-based catalysts.

View Article and Find Full Text PDF

Background: Alpha-synuclein (ɑ-syn) plays a key role in Parkinson's disease (PD) pathogenesis, but existing studies have found mixed results regarding the associations between plasma ɑ-syn and the development of cognitive impairment. We aim to clarify the potentially important relationship between ɑ-syn level in plasma and development of cognitive impairment in PD through systematic review and meta-analysis.

Methods: A systematic search was conducted in the PubMed, Embase and Web of Science databases for studies reporting plasma ɑ-syn concentrations and cognitive impairment in PD.

View Article and Find Full Text PDF

Introduction: This study investigated the cortical and subcortical gray matter volume (GMV) and cognitive impairment (CI) in patients with Parkinson's disease (PD).

Methods: In this study, T1-weighted magnetic resonance imaging of the cortex and subcortex was conducted on 92 individuals diagnosed with PD and 92 healthy controls (HCs). PD patients were divided into three groups: PD with normal cognition (PD-NC,  = 21), PD with mild CI (PD-MCI,  = 43), and PD with severe CI (PD-SCI,  = 28).

View Article and Find Full Text PDF

Association of plasma homocysteine with cognitive impairment in patients with Parkinson's disease.

Front Aging Neurosci

December 2024

Department of Neurology and National Research Center for Aging and Medicine and National Center for Neurological Disorders, State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.

Background: Elevated plasma homocysteine (Hcy) has been reported as a risk factor for cognitive impairment in the general population. However, there are conflicting results regarding the relationship between Hcy and cognitive impairment across various cognitive domains in Parkinson's disease (PD).

Objective: This study aims to explore the association between plasma Hcy levels, cognitive impairment, and dysfunction in various cognitive domains among PD patients with and without mild cognitive impairment (MCI).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!